Entyvio 64764-0300-20
Generic: Vedolizumab
- Manufacturer
- Takeda Pharmaceuticals America, Inc.
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- May 20, 2014
- Listing Expires
- December 31, 2027
- Application
- BLA125476
Need to source Entyvio? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Vedolizumab | 300 mg/5mL |
Drug Class
Integrin Receptor Antagonist [EPC]Integrin Receptor Antagonist [EPC]Integrin Receptor Antagonists [MoA]
Selected Package
64764-0300-20Selected1 VIAL, SINGLE-DOSE in 1 CARTON (64764-300-20) / 5 mL in 1 VIAL, SINGLE-DOSE